Concepedia

Xiaozhang Zheng

XZ

Statistics

Publications

35

Citations

1.5K

H-Index

21

Active since

1995

Affiliations

Forma Therapeutics (United States)(Current)

University of Tennessee Health Science Center

Woomera Therapeutics

Albany Molecular Research (United States)

MSD (UK) Limited (United Kingdom)

Xiaozhang Zheng is an author at Forma Therapeutics (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1995–2025

35

Publications

35

Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6

Nina Kerres, Steffen Steurer, Stefanie Schlager et al. · Cell Reports · 2017 · 206 citations · Full text

, , +11

IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial

Lindsay Ackerman, Gerard Acloque, Sandro Bacchelli et al. · Nature Medicine · 2023 · 119 citations · Full text

, , +17

Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2

Namrata Bora-Singhal, Durairaj Mohankumar, Biswarup Saha et al. · Scientific Reports · 2020 · 94 citations · Full text

, , +17

Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors

Xiaozhang Zheng, Paul Bauer, Timm Baumeister et al. · Journal of Medicinal Chemistry · 2013 · 81 citations · Full text

, , +17

Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors

Xiaozhang Zheng, Paul Bauer, Timm Baumeister et al. · Journal of Medicinal Chemistry · 2013 · 71 citations · Full text

, , +13

1–5 of 35